Franssen EJ - Search Results

1

Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.

Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA. Jager PL, et al. Among authors: franssen ej. J Nucl Med. 1998 Apr;39(4):699-706. J Nucl Med. 1998. PMID: 9544684 Free article.

2

Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors.

Jager PL, Franssen EJ, Kool W, Szabó BG, Hoekstra HJ, Groen HJ, de Vries EG, van Imhoff GW, Vaalburg W, Piers DA. Jager PL, et al. Among authors: franssen ej. J Nucl Med. 1998 Oct;39(10):1736-43. J Nucl Med. 1998. PMID: 9776279 Free article.

3

Measurement of free fatty acid kinetics during non-equilibrium tracer conditions in man: implications for the estimation of the rate of appearance of free fatty acids.

Riemens SC, Dullaart RP, Franssen EJ, Piers DA, Reitsma WD, Sluiter WJ. Riemens SC, et al. Among authors: franssen ej. Eur J Clin Invest. 1998 Feb;28(2):108-14. doi: 10.1046/j.1365-2362.1998.00249.x. Eur J Clin Invest. 1998. PMID: 9541124 Clinical Trial.

4

99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours.

Bakker M, van der Graaf WT, Piers DA, Franssen EJ, Groen HJ, Smit EF, Kool W, Hollema H, Müller EA, De Vries EG. Bakker M, et al. Among authors: franssen ej. Anticancer Res. 1999 May-Jun;19(3B):2349-53. Anticancer Res. 1999. PMID: 10472354

5

99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.

Hendrikse NH, Franssen EJ, van der Graaf WT, Meijer C, Piers DA, Vaalburg W, de Vries EG. Hendrikse NH, et al. Among authors: franssen ej. Br J Cancer. 1998;77(3):353-8. doi: 10.1038/bjc.1998.57. Br J Cancer. 1998. PMID: 9472628 Free PMC article.

6

Characterization of pulmonary and myocardial beta-adrenoceptors with S-1'-[fluorine-18]fluorocarazolol.

Visser TJ, van Waarde A, van der Mark TW, Kraan J, Elsinga PH, Pruim J, Ensing K, Jansen T, Willemsen AT, Franssen EJ, Visser GM, Paans AM, Vaalburg W. Visser TJ, et al. Among authors: franssen ej. J Nucl Med. 1997 Feb;38(2):169-74. J Nucl Med. 1997. PMID: 9025729 Free article.

7

Pharmacokinetics and dosimetry of cobalt-55 and cobalt-57.

Jansen HM, Knollema S, van der Duin LV, Willemsen AT, Wiersma A, Franssen EJ, Russel FG, Korf J, Paans AM. Jansen HM, et al. Among authors: franssen ej. J Nucl Med. 1996 Dec;37(12):2082-6. J Nucl Med. 1996. PMID: 8970539 Free article.

8

Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.

Elsinga PH, Franssen EJ, Hendrikse NH, Fluks L, Weemaes AM, van der Graaf WT, de Vries EG, Visser GM, Vaalburg W. Elsinga PH, et al. Among authors: franssen ej. J Nucl Med. 1996 Sep;37(9):1571-5. J Nucl Med. 1996. PMID: 8790221 Free article.

9

Visualization of damaged brain tissue after ischemic stroke with cobalt-55 positron emission tomography.

Jansen HM, Pruim J, vd Vliet AM, Paans AM, Hew JM, Franssen EJ, de Jong BM, Kosterink JG, Haaxma R, Korf J. Jansen HM, et al. Among authors: franssen ej. J Nucl Med. 1994 Mar;35(3):456-60. J Nucl Med. 1994. PMID: 8113896 Free article.

10

Visualization of multidrug resistance in vivo.

Hendrikse NH, Franssen EJ, van der Graaf WT, Vaalburg W, de Vries EG. Hendrikse NH, et al. Among authors: franssen ej. Eur J Nucl Med. 1999 Mar;26(3):283-93. doi: 10.1007/s002590050390. Eur J Nucl Med. 1999. PMID: 10079321 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page